TB-500 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-10-24. Numbers and descriptions here follow the published literature rather than marketing material.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
| Property | Value | Notes |
|---|---|---|
| Analytical method | LC-MS/MS | Preferred confirmatory technique |
| Appearance | White to off-white powder | Lyophilised form |
| Solubility | Freely soluble in water | Also described in saline |
| Storage temperature | Below -20 °C for powder | Short-term refrigeration for solutions |
| Regulatory status | Prohibited in sport | Listed under peptide hormones |
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
Once dissolved, the peptide is far less stable than the dry powder. Aqueous solutions are subject to hydrolysis, oxidation at susceptible residues and gradual loss of material through adsorption onto glass and plastic surfaces. Terminal glutamine can cyclise under some conditions, producing a related species that complicates purity assessment. Dilute solutions tend to lose a larger fraction of material to surfaces than concentrated ones. Buffers, pH and ionic strength all influence the rate of change, so stability figures are only meaningful when those parameters are stated alongside the storage interval.
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
The most diverse and richest forests are the mixed-mesophytic or medium-moisture types, which are largely confined to rich, moist montane soils of the southern and central Appalachians, particularly in the Cumberland and Allegheny Mountains, but also thrive in the southern Appalachian coves. Characteristic canopy species are white basswood (Tilia heterophylla), yellow buckeye (Aesculus octandra), sugar maple (Acer saccharum), American beech (Fagus grandifolia), tuliptree (Liriodendron tulipifera), white ash (Fraxinus americana) and yellow birch (Betula alleganiensis). Other common trees are red maple (Acer rubrum), shagbark and bitternut hickories (Carya ovata and C. cordiformis) and black or sweet birch (Betula lenta ). Small understory trees and shrubs include paw paw (Asimina tribola), flowering dogwood (Cornus florida), hophornbeam (Ostrya virginiana), witch-hazel (Hamamelis virginiana) and spicebush (Lindera benzoin). There are also hundreds of perennial and annual herbs, among them such herbal and medicinal plants as American ginseng (Panax quinquefolius), goldenseal (Hydrastis canadensis), bloodroot (Sanguinaria canadensis) and black cohosh (Cimicifuga racemosa). The foregoing trees, shrubs, and herbs are also more widely distributed in less rich mesic forests that generally occupy coves, stream valleys and flood plains throughout the southern and central Appalachians at low and intermediate elevations.
== In popular culture == Dorothy L. Sayers's short story "The Leopard Lady", in the 1939 collection In the Teeth of the Evidence, features a child poisoned by potato berries injected with solanine to increase their toxicity. Inio Asano named one of his manga after the chemical: Solanin.
Thus, the molar mass of a substance X can be calculated as M(X) = Ar(X) ⋅ Mu, with the molar mass constant Mu equal to exactly 1 Da/ent, which (for all practical purposes) is equal to 1 g/mol, as the mole was historically defined such that the Avogadro number (the number of atomic-scale entities comprising one mole) was exactly equal to the number of daltons in a gram (g/Da). This means that (for all practical purposes): 1 mol = (g/Da) ent. The relationship between the molar mass of carbon-12, M(12C) = 12 g/mol, and its atomic mass, ma(12C) = 12 Da, can be expressed as M(12C) = ma(12C) · NA. Rearranging and substituting the given values into the equation yields the following expression for the Avogadro constant: NA = (g/Da) mol−1, making the Avogadro number equal to the number of daltons in a gram, and equivalently the number of atoms in 12 grams of carbon-12 (as in the 1971 definition of the mole). The mole was defined in such a way that the numerical value of the molar mass of a substance in g/mol, i.e. M(X)/(g/mol), was equal to the numerical value of the average mass of one entity (atom, molecule, formula unit) in Da, i.e. ma(X)/Da = Ar(X), so that M(X) = Ar(X) g/mol. The equivalence was exact before the redefinition of the mole in 2019, and is now only approximate, but equality may still be assumed with high accuracy. Thus, for example, the average mass of a molecule of water is about 18.0153 Da, and the molar mass of water is about 18.0153 g/mol.
Sources: en.wikipedia.org
=== Settlements === Russian Cossacks founded numerous settlements (stanitsas) and fortresses along troublesome borders. These included the forts Verny (Almaty, Kazakhstan) in south Central Asia; Grozny in North Caucasus; Fort Alexandrovsk (Fort Shevchenko, Kazakhstan); Krasnovodsk (Turkmenbashi, Turkmenistan); Novonikolayevskaya stanitsa (Bautino, Kazakhstan); Blagoveshchensk; and towns and settlements along the Ural, Ishim, Irtysh, Ob, Yenisei, Lena, Amur, Anadyr (Chukotka), and Ussuri Rivers. A group of Albazin Cossacks settled in China as early as 1685. Cossacks interacted with nearby peoples and exchanged cultural influences (the Terek Cossacks, for example, were heavily influenced by the culture of North Caucasian tribes). They also frequently intermarried with local non-Cossack settlers and local inhabitants, regardless of race or origin, sometimes setting aside religious restrictions. War brides brought from distant lands were also common in Cossack families. General Bogaevsky, a commander in the Russian Volunteer Army, mentions in his 1918 memoir that one of his Cossacks, Sotnik Khoperski, was a native Chinese who had been brought back as a child from Manchuria during the Russian-Japanese War of 1904–1905 and adopted and raised by a Cossack family. Cossacks initially relied on raiding, herding, fishing and hunting, despising agriculture as lowly. After the defeat of Stenka Razin in 1672, the Cossacks began transitioning to agriculture, but this would remain a secondary concern for Cossacks until the late 19th century.
Glutathione S-transferase Mu 4 is an enzyme that in humans is encoded by the GSTM4 gene. Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase that belongs to the mu class. The mu class of enzymes functions in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of certain drugs. Diversification of these genes has occurred in regions encoding substrate-binding domains, as well as in tissue expression patterns, to accommodate an increasing number of foreign compounds. Multiple transcript variants, each encoding a distinct protein isoform, have been identified. In the August 2009 issue of Oncogene journal, researchers at Huntsman Cancer Institute (HCI) at the University of Utah demonstrated that expression levels of GSTM4 could predict response to chemotherapy in patients with Ewing sarcoma. The study found that patients who did not respond to chemotherapy had high levels of GSTM4.
=== Zymogen activation === Zymogens are the usually inactive precursors of an enzyme. If the digestive enzymes were active when synthesized, they would immediately start chewing up the synthesizing organs and tissues. Acute pancreatitis is such a condition, in which there is premature activation of the digestive enzymes in the pancreas, resulting in self-digestion (autolysis). It also complicates postmortem investigations, as the pancreas often digests itself before it can be assessed visually. Zymogens are large, inactive structures, which have the ability to break apart or change into the smaller activated enzymes. The difference between zymogens and the activated enzymes lies in the fact that the active site for catalysis of the zymogens is distorted. As a result, the substrate polypeptide cannot bind effectively, and proteolysis does not occur. Only after activation, during which the conformation and structure of the zymogen change and the active site is opened, can proteolysis occur.
In Algiers, the capital of Algeria, captured Christians and Europeans were forced into slavery. In about 1650, there were as many as 35,000 Christian slaves in Algiers. By one estimate, raids by Barbary slave traders on coastal villages and ships extending from Italy to Iceland, enslaved an estimated 1 to 1.25 million Europeans between the 16th and 19th centuries. However, this estimate is the result of an extrapolation which assumes that the number of European slaves captured by Barbary pirates was constant for a 250-year period:
Sources: en.wikipedia.org
==== Air embolism ==== The prosecution cited a 1989 study by Shoo Lee and A. K. Tanswell to argue that skin discolouration observed on some infants was indicative of air embolism. After reviewing the descriptions of the discolouration, Lee said he did not consider them suggestive of air embolism and described diagnosing the condition by ruling out other causes as "a fundamental mistake of medicine". The defence sought to call Lee as an expert witness during an appeal in 2024, but the Court of Appeal ruled his evidence inadmissible on the basis that he could have been called at trial and that the prosecution had not relied solely on skin discolouration to support the diagnosis. Lee has since published an updated version of his 1989 paper, arguing that venous air embolism has never been documented to cause patchy skin discolouration. Abid Qazi, a former NHS paediatric surgeon whose case report was cited in a prosecution expert's analysis, reviewed one of the cases and expressed scepticism about the diagnosis, saying he believed Letby had been "a victim of the poor NHS system". The Lee panel proposed alternative explanations for the incidents attributed to air embolism and concluded that there was no evidence of the condition.
=== Alpha-2 agonists === These are sympathomimetic drugs that activate alpha-2 receptors or enhance their effects. Because alpha-2 receptors are inhibitory and many are located presynaptically on norepinephrine-releasing cells, the net effect of these drugs is usually to reduce the amount of norepinephrine released. Drugs in this group that are capable of entering the brain often have strong sedating effects, due to their inhibitory effects on the locus coeruleus. Clonidine and guanfacine, for example, are used for the treatment of anxiety disorders and insomnia, and also as a sedative premedication for patients about to undergo surgery. Xylazine, another drug in this group, is also a powerful sedative and is often used in combination with ketamine as a general anaesthetic for veterinary surgery—in the United States it has not been approved for use in humans.
PEGylation is the process of attaching the strands of the polymer PEG to molecules, most typically peptides, proteins, and antibody fragments, that can improve the safety and efficiency of many therapeutics. It produces alterations in the physiochemical properties including changes in conformation, electrostatic binding, hydrophobicity etc. These physical and chemical changes increase systemic retention of the therapeutic agent. Also, it can influence the binding affinity of the therapeutic moiety to the cell receptors and can alter the absorption and distribution patterns. PEGylation, by increasing the molecular weight of a molecule, can impart several significant pharmacological advantages over the unmodified form, such as improved drug solubility, reduced dosage frequency with potentially reduced toxicity and without diminished efficacy, extended circulating life, increased drug stability, and enhanced protection from proteolytic degradation; PEGylated forms may also be eligible for patent protection.
Sources: en.wikipedia.org
The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.
Dry lyophilised powder is normally kept frozen and protected from moisture and light. Dissolved material is handled cold and used promptly to limit degradation.
It is not licensed as a medicine in major markets and is distributed as a research chemical. Sports organisations prohibit its use, and some countries restrict import and supply.
No. Thymosin beta-4 is a 43-residue natural peptide, while TB-500 is a commercial label applied to a short synthetic fragment of it. The two differ in length, sequence coverage and how they are handled in the laboratory.